{"id":8587,"date":"2026-01-13T09:16:18","date_gmt":"2026-01-13T14:16:18","guid":{"rendered":"https:\/\/www.curingheartdisease.com\/?p=8587"},"modified":"2026-07-16T10:59:06","modified_gmt":"2026-07-16T14:59:06","slug":"%e5%bf%83%e7%96%be%e6%82%a3%e6%b2%bb%e7%99%82%e3%81%ae%e6%9c%aa%e6%9d%a5","status":"publish","type":"post","link":"https:\/\/www.curingheartdisease.com\/ja\/the-future-of-heart-disease-management\/","title":{"rendered":"\u5fc3\u75be\u60a3\u7ba1\u7406\u306e\u672a\u6765"},"content":{"rendered":"

The Technological Renaissance in Preventive Cardiology – Artificial Intelligence, Quantitative Coronary Tomography<\/h2>\n

\u306f\u3058\u3081\u306b<\/h3>\n

Cardiovascular medicine is undergoing a substantive paradigm shift, moving from a predominantly reactive, symptom-driven model toward a preventive framework grounded in early detection and individualized risk assessment. At the center of this transition is the integration of artificial intelligence (AI) with coronary computed tomography angiography (CCTA), particularly through the development of atherosclerosis imaging\u2013quantitative computed tomography (AI-QCT). This approach addresses a long-standing limitation in cardiology: the inability of traditional diagnostic tools to reliably detect non-obstructive, lipid-rich coronary plaque, despite such lesions being responsible for the majority of acute coronary syndromes and sudden cardiac death events (1).<\/p>\n

The clinical relevance of this limitation is substantial. Epidemiologic and pathologic studies consistently demonstrate that most myocardial infarctions arise from plaques that were not flow-limiting prior to rupture (2). As cardiovascular disease remains the leading cause of mortality worldwide, with annual deaths projected to exceed 20 million by 2030, improved methods for identifying high-risk coronary atherosclerosis before clinical events occur are increasingly necessary (3).<\/p>\n

\"\"<\/h3>\n

 <\/p>\n

\"\"<\/h3>\n

\"\"\"\"<\/h3>\n

\u5fc3\u8840\u7ba1\u30ea\u30b9\u30af\u5c64\u5225\u5316\u306e\u9032\u5316\u3068\u52d5\u8108\u786c\u5316\u306e\u751f\u7269\u5b66<\/h3>\n

Traditional cardiovascular risk stratification relies on indirect markers such as serum lipid levels, blood pressure, glycemic control, smoking status, and demographic variables incorporated into population-based risk calculators. While these models have proven useful at a population level, they often lack precision when applied to individual patients, particularly those with apparently \u201cnormal\u201d risk factor profiles who nonetheless harbor significant subclinical disease (4).<\/p>\n

Atherosclerosis is a chronic inflammatory disease of the arterial wall rather than a disorder defined solely by luminal obstruction. Plaque develops within the intima and consists of varying proportions of lipid, fibrous tissue, inflammatory cells, and calcium. Conventional diagnostic tests\u2014including exercise stress testing, electrocardiography, and invasive coronary angiography\u2014primarily detect disease once it produces hemodynamically significant stenosis, typically defined as luminal narrowing of 70% or greater (5).<\/p>\n

Insight 1:<\/strong> Autopsy and angiographic studies demonstrate that approximately 70\u201375% of myocardial infarctions occur in vessels with less than 50% stenosis prior to the index event, indicating that most patients who experience acute coronary syndromes would not have been identified as high risk by standard stress testing alone (2).<\/p>\n

Insight 2:<\/strong> Coronary artery calcium scoring (CACS) was developed to improve detection of subclinical disease by identifying calcified plaque. However, CACS does not detect non-calcified plaque, and a calcium score of zero does not exclude the presence of lipid-rich, rupture-prone lesions (6).<\/p>\n

Insight 3:<\/strong> AI-QCT enables non-invasive quantification of total coronary plaque burden, including low-density non-calcified plaque, which has been shown to carry a higher association with future cardiovascular events than stenosis severity alone (7).<\/p>\n\n\n\n\n\n\n\n\n
Plaque Characteristic<\/strong><\/td>\nVisibility (CACS)<\/strong><\/td>\nVisibility (Standard CCTA)<\/strong><\/td>\nVisibility (AI-QCT)<\/strong><\/td>\nClinical Risk Profile<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Calcified plaque<\/td>\n\u9ad8<\/td>\n\u9ad8<\/td>\n\u9ad8<\/td>\nGenerally stable; marker of chronic disease<\/td>\n<\/tr>\n
\u975e\u77f3\u7070\u5316\u30d7\u30e9\u30fc\u30af<\/td>\nNone<\/td>\nQualitative \/ limited<\/td>\nQuantitative \/ high<\/td>\nElevated rupture risk<\/td>\n<\/tr>\n
Low-density plaque<\/td>\nNone<\/td>\nVariable<\/td>\n\u9ad8<\/td>\nStrong association with ACS<\/td>\n<\/tr>\n
Total plaque volume<\/td>\nNone<\/td>\nIndirect estimate<\/td>\nPrecise (mm\u00b3)<\/td>\nStrong predictor of future events<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Technical Architecture of AI-Enabled Coronary Analysis<\/h3>\n

AI-QCT platforms perform voxel-level analysis of the coronary tree rather than relying on visual interpretation alone. These systems employ deep-learning architectures\u2014including convolutional neural networks (CNNs), three-dimensional U-Net segmentation models, and VGG-derived classifiers\u2014trained on large, curated datasets that link imaging features with invasive validation and long-term clinical outcomes (8).<\/p>\n

Insight 4:<\/strong> AI-QCT begins with acquisition of high-resolution CCTA. Contemporary multi-detector CT systems, including 64- and 640-slice scanners, provide the temporal and spatial resolution necessary to minimize motion artifact and enable accurate segmentation of coronary anatomy (5).<\/p>\n

Insight 5:<\/strong> Automated algorithms identify the coronary lumen and vessel wall and classify plaque components according to Hounsfield unit attenuation values, allowing differentiation of lipid-rich, fibrous, and calcified tissue (9).<\/p>\n

Insight 6:<\/strong> AI-derived ischemia indices integrate plaque morphology, lesion length, vessel remodeling, and luminal geometry to estimate flow limitation, providing a non-invasive correlate of invasive fractional flow reserve (FFR) (10).<\/p>\n

Clinical Validation and Peer-Reviewed Evidence<\/h3>\n

AI-QCT has been evaluated in multiple prospective trials, registries, and comparative studies published in leading cardiovascular and imaging journals, including Journal of the American College of Cardiology<\/em>, Circulation: Cardiovascular Imaging<\/em>, \u3001\u304a\u3088\u3073 European Heart Journal \u2013 Cardiovascular Imaging<\/em> (11).<\/p>\n

Landmark Trials and Registries<\/h3>\n

Insight 7:<\/strong> The CREDENCE trial demonstrated close agreement between AI-assisted CCTA analysis and invasive quantitative coronary angiography and FFR, supporting the diagnostic accuracy of AI-QCT for identifying hemodynamically significant disease (12).<\/p>\n

Insight 8:<\/strong> The CONFIRM2 registry, encompassing tens of thousands of patients across multiple countries, showed that AI-quantified plaque features identify a wide gradient of cardiovascular risk among patients with non-obstructive coronary artery disease (7).<\/p>\n

Insight 9:<\/strong> The CERTAIN study demonstrated that AI-QCT significantly improved diagnostic certainty compared with standard interpretation, resulting in more appropriate medical therapy and fewer unnecessary downstream tests (1).<\/p>\n\n\n\n\n\n\n\n\n
\u52c9\u5f37<\/strong><\/td>\nN<\/strong><\/td>\n\u4e3b\u306a\u767a\u898b<\/strong><\/td>\nP-value<\/strong><\/td>\nClinical Implication<\/strong><\/td>\n<\/tr>\n<\/thead>\n
CONFIRM2<\/td>\n6,550<\/td>\nAUC for MACE improved from 0.62 to 0.75<\/td>\n<0.001<\/td>\nImproved prognostic accuracy<\/td>\n<\/tr>\n
CREDENCE<\/td>\n513<\/td>\nHigh concordance with invasive FFR<\/td>\n<0.01<\/td>\nViable non-invasive ischemia assessment<\/td>\n<\/tr>\n
PACIFIC-1<\/td>\n208<\/td>\nAI exceeded expert readers<\/td>\n<0.05<\/td>\nReduced inter-observer variability<\/td>\n<\/tr>\n
PROMISE (subset)<\/td>\n4,347<\/td>\n41% stenoses reclassified<\/td>\n\u2014<\/td>\nReduced false positives<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Preventive Cardiology Implementation and Longitudinal Disease Monitoring<\/h3>\n

Integration of AI-QCT into preventive cardiology workflows shifts the clinical focus from episodic evaluation toward longitudinal monitoring of atherosclerotic disease.<\/p>\n

Insight 10:<\/strong> Quantification of total plaque burden enables objective assessment of disease progression or regression over time, facilitating a treat-to-target approach guided by serial imaging (7).<\/p>\n

Insight 11:<\/strong> AI-based comparison tools permit evaluation of changes in plaque composition, including stabilization or regression of lipid-rich plaque in response to medical therapy (13).<\/p>\n

Hardware Advances: Photon-Counting Computed Tomography<\/strong><\/p>\n

The performance of AI-QCT is dependent on the quality of input imaging data, which continues to improve with advances in CT hardware.<\/p>\n

Insight 12:<\/strong> Photon-counting CT (PCCT) systems directly convert X-ray photons into electrical signals, reducing electronic noise and calcium blooming artifacts compared with conventional energy-integrating detectors (14).<\/p>\n

Insight 13:<\/strong> PCCT provides higher spatial resolution with lower radiation and contrast dose, expanding eligibility for coronary CT imaging to patients with high heart rates, elevated body mass index, or extensive coronary calcification (15).<\/p>\n

Economic and Health System Implications<\/strong><\/p>\n

The adoption of AI-enabled cardiac imaging aligns with broader healthcare trends toward value-based care and prevention.<\/p>\n

Insight 14:<\/strong> Market analyses project rapid growth of AI applications in cardiology, driven by improved diagnostic efficiency and potential reductions in downstream costs associated with acute coronary events (16).<\/p>\n

Insight 15:<\/strong> Early identification of high-risk plaque phenotypes may reduce myocardial infarction rates and associated healthcare expenditures by enabling earlier and more targeted intervention (17).<\/p>\n

Conclusions and Future Directions<\/h3>\n

Preventive cardiology is increasingly transitioning toward a biologically informed model that emphasizes plaque burden and composition rather than stenosis severity alone. AI-QCT provides a reproducible, quantitative framework for assessing coronary atherosclerosis before clinical events occur.<\/p>\n

Insight 16:<\/strong> Future developments are likely to include integration of agentic AI systems, longitudinal digital heart models, and multimodal data streams incorporating genomic and metabolic information (18).<\/p>\n

Insight 17:<\/strong> As AI assumes a greater role in image interpretation and quantification, clinicians may increasingly focus on higher-level clinical decision-making, risk communication, and individualized therapy optimization (19).<\/p>\n

\u53c2\u8003\u6587\u732e<\/h3>\n
    \n
  1. Nurmohamed NS, Cole JH, Budoff MJ, et al. Impact of atherosclerosis imaging-quantitative computed tomography on diagnostic certainty, downstream testing, coronary revascularization, and medical therapy: the CERTAIN study.\u00a0Eur Heart J Cardiovasc Imaging<\/i>. 2024;25(6):857-866. doi:10.1093\/ehjci\/jeae029<\/li>\n
  2. Falk E, Shah PK, Fuster V. Coronary plaque disruption.\u00a0\u5faa\u74b0<\/i>. 1995;92(3):657-671. doi:10.1161\/01.cir.92.3.657<\/li>\n
  3. Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023.\u00a0\u7c73\u56fd\u5fc3\u81d3\u75c5\u5b66\u4f1a\u8a8c<\/i>. 2025;86(22):2167-2243. doi:10.1016\/j.jacc.2025.08.015<\/li>\n
  4. Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions.\u00a0\u5faa\u74b0<\/i>. 2010;121(15):1768-1777. doi:10.1161\/CIRCULATIONAHA.109.849166<\/li>\n
  5. Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of anatomical versus functional testing for coronary artery disease.\u00a0\u30cb\u30e5\u30fc\u30a4\u30f3\u30b0\u30e9\u30f3\u30c9\u30fb\u30b8\u30e3\u30fc\u30ca\u30eb\u30fb\u30aa\u30d6\u30fb\u30e1\u30c7\u30a3\u30b7\u30f3<\/i>. 2015;372(14):1291-1300. doi:10.1056\/NEJMoa1415516<\/li>\n
  6. Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary Calcium Score and Cardiovascular Risk.\u00a0\u7c73\u56fd\u5fc3\u81d3\u75c5\u5b66\u4f1a\u8a8c<\/i>. 2018;72(4):434-447. doi:10.1016\/j.jacc.2018.05.027<\/li>\n
  7. Feuchtner GM, Lacaita PG, Bax JJ, et al. AI-Quantitative CT Coronary Plaque Features Associate With a Higher Relative Risk in Women: CONFIRM2 Registry.\u00a0Circ Cardiovasc Imaging<\/i>. 2025;18(6):e018235. doi:10.1161\/CIRCIMAGING.125.018235<\/li>\n
  8. Oikonomou EK, Khera R. Machine learning in precision diabetes care and cardiovascular risk prediction.\u00a0Cardiovasc Diabetol<\/i>. 2023;22(1):259. Published 2023 Sep 25. doi:10.1186\/s12933-023-01985-3<\/li>\n
  9. Koo BK, Yang S, Jung JW, et al. Artificial Intelligence-Enabled Quantitative Coronary Plaque and Hemodynamic Analysis for Predicting Acute Coronary Syndrome.\u00a0JACC Cardiovasc Imaging<\/i>. 2024;17(9):1062-1076. doi:10.1016\/j.jcmg.2024.03.015<\/li>\n
  10. N\u00f8rgaard BL, Leipsic J, Gaur S, et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps).\u00a0\u7c73\u56fd\u5fc3\u81d3\u75c5\u5b66\u4f1a\u8a8c<\/i>. 2014;63(12):1145-1155. doi:10.1016\/j.jacc.2013.11.043<\/li>\n
  11. Beerkens FJ, Tang GHL, Kini AS, et al. Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art Review.\u00a0\u7c73\u56fd\u5fc3\u81d3\u75c5\u5b66\u4f1a\u8a8c<\/i>. 2025;85(9):944-964. doi:10.1016\/j.jacc.2024.11.051<\/li>\n
  12. Griffin WF, Choi AD, Riess JS, et al. AI Evaluation of Stenosis on Coronary CTA, Comparison With Quantitative Coronary Angiography and Fractional Flow Reserve: A CREDENCE Trial Substudy.\u00a0JACC Cardiovasc Imaging<\/i>. 2023;16(2):193-205. doi:10.1016\/j.jcmg.2021.10.020<\/li>\n
  13. Zaman S, Wasfy JH, Kapil V, et al. The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma.\u00a0\u30e9\u30f3\u30bb\u30c3\u30c8<\/i>. 2025;405(10486):1264-1312. doi:10.1016\/S0140-6736(25)00055-8<\/li>\n
  14. Willemink MJ, Persson M, Pourmorteza A, Pelc NJ, Fleischmann D. Photon-counting CT: Technical Principles and Clinical Prospects.\u00a0Radiology<\/i>. 2018;289(2):293-312. doi:10.1148\/radiol.2018172656<\/li>\n
  15. Schiebler ML, Jinzaki M, Yanagawa M, et al. Future Applications of Cardiothoracic CT.\u00a0Radiology<\/i>. 2025;315(3):e240085. doi:10.1148\/radiol.240085<\/li>\n
  16. Windecker S, Gilard M, Achenbach S, et al. Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table.\u00a0\u6b27\u5dde\u5fc3\u81d3\u75c5\u5b66\u4f1a\u8a8c<\/i>. 2024;45(13):1104-1115. doi:10.1093\/eurheartj\/ehae069<\/li>\n
  17. Undas A, Musia\u0142 J, Z\u0105bczyk M. Antiphospholipid antibodies and atherosclerotic vascular disease: recent advances.\u00a0Rheumatol Int<\/i>. 2025;45(12):279. Published 2025 Nov 29. doi:10.1007\/s00296-025-06050-8<\/li>\n
  18. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence.\u00a0Nat Med<\/i>. 2019;25(1):44-56. doi:10.1038\/s41591-018-0300-7<\/li>\n
  19. Shetty NS, Gaonkar M, Pampana A, et al. Association of Pathogenic\/Likely Pathogenic Inherited Cardiomyopathy Variants With Heart Failure: A TOPMed Multiancestry Analysis.\u00a0Mayo Clin Proc<\/i>. 2025;100(11):1948-1955. doi:10.1016\/j.mayocp.2025.01.021<\/li>\n<\/ol>","protected":false},"excerpt":{"rendered":"

    \u3042\u306a\u305f\u306f\u7f8e\u3057\u3044\u5bb6\u3092\u898b\u3066\u3044\u307e\u3059\u3002\u829d\u751f\u306f\u5b8c\u74a7\u306a\u7dd1\u8272\u3092\u3057\u3066\u3044\u307e\u3059\u3002\u7a93\u306f\u304d\u308c\u3044\u306b\u78e8\u304b\u308c\u3066\u8f1d\u3044\u3066\u3044\u307e\u3059\u3002\u901a\u308a\u304b\u3089\u898b\u308b\u3068\u3001\u305d\u306e\u5bb6\u306f\u307e\u308b\u3067\u65b0\u7bc9\u306e\u3088\u3046\u3067\u3059\u3002\u3057\u304b\u3057\u3001\u58c1\u306e\u88cf\u5074\u306b\u306f\u300c\u6a5f\u68b0\u306e\u4e2d\u306e\u5e7d\u970a\u300d\u304c\u6f5c\u3093\u3067\u3044\u307e\u3059\u3002\u6c34\u9053\u7ba1\u306f\u53e4\u304f\u9306\u3073\u3066\u3044\u307e\u3059\u3002\u96fb\u7dda\u306f\u307b\u3064\u308c\u3066\u706b\u82b1\u3092\u6563\u3089\u3057\u3066\u3044\u307e\u3059\u3002\u5916\u89b3\u3092\u898b\u305f\u3060\u3051\u3067\u306f\u3001\u3053\u308c\u3089\u306e\u554f\u984c\u306f\u898b\u3048\u307e\u305b\u3093\u3002\u3042\u308b\u65e5\u3001\u30d1\u30a4\u30d7\u304c\u7834\u88c2\u3059\u308b\u304b\u3001\u706b\u707d\u304c\u767a\u751f\u3057\u307e\u3059\u3002\u8ab0\u3082\u304c\u30b7\u30e7\u30c3\u30af\u3092\u53d7\u3051\u307e\u3059\u3002\u5f7c\u3089\u306f\u8a00\u3044\u307e\u3059\u3002\u300c\u3067\u3082\u3001\u3042\u3093\u306a\u306b\u304d\u308c\u3044\u306a\u5bb6\u3060\u3063\u305f\u306e\u306b\uff01\u300d\u201c<\/p>","protected":false},"author":16,"featured_media":8592,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[219,220,233,225],"tags":[],"class_list":["post-8587","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lipids-medications-and-testing","category-medications-and-treatments","category-risk-screening","category-risk-genetics-special-populations"],"acf":[],"yoast_head":"\nThe Future of Heart Disease Management - The Premiere Heart Health Education Platform<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.curingheartdisease.com\/ja\/\u5fc3\u75be\u60a3\u6cbb\u7642\u306e\u672a\u6765\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Future of Heart Disease Management - The Premiere Heart Health Education Platform\" \/>\n<meta property=\"og:description\" content=\"Imagine you are looking at a beautiful house. The lawn is a perfect green. The windows are clean and shiny. From the street, the house looks brand new. But behind the walls, there is a "ghost in the machine." The water pipes are old and rusty. The electric wires are fraying and sparking. You cannot see these problems just by looking at the outside. One day, a pipe bursts or a fire starts. Everyone is shocked. They say, "But the house looked so good!"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.curingheartdisease.com\/ja\/\u5fc3\u75be\u60a3\u6cbb\u7642\u306e\u672a\u6765\/\" \/>\n<meta property=\"og:site_name\" content=\"The Premiere Heart Health Education Platform\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/curingheartdisease\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-13T14:16:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-16T14:59:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/01\/post-image-21.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Peter Megdal PhD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RMHDInc\" \/>\n<meta name=\"twitter:site\" content=\"@RMHDInc\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Peter Megdal PhD\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"9\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/\"},\"author\":{\"name\":\"Peter Megdal PhD\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\"},\"headline\":\"The Future of Heart Disease Management\",\"datePublished\":\"2026-01-13T14:16:18+00:00\",\"dateModified\":\"2026-07-16T14:59:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/\"},\"wordCount\":1629,\"publisher\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/post-image-21.jpg\",\"articleSection\":[\"Lipids, Medications and Testing\",\"Medications and Treatments\",\"Risk Screening\",\"Risk, Genetics and Special Populations\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/\",\"name\":\"The Future of Heart Disease Management - The Premiere Heart Health Education Platform\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/post-image-21.jpg\",\"datePublished\":\"2026-01-13T14:16:18+00:00\",\"dateModified\":\"2026-07-16T14:59:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/post-image-21.jpg\",\"contentUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/post-image-21.jpg\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/the-future-of-heart-disease-management\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.curingheartdisease.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Future of Heart Disease Management\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#website\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/\",\"name\":\"The Premiere Heart Health Education Platform\",\"description\":\"To make available to the public the state of the art information on how to reverse heart disease. This is an evidence-based organization utilizing the best available science, including diet, exercise drugs, and other resources to best fight this disease.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.curingheartdisease.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\",\"name\":\"Curing Heart Disease, LLC\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-Curing-Heart-icon-red.png\",\"contentUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-Curing-Heart-icon-red.png\",\"width\":512,\"height\":512,\"caption\":\"Curing Heart Disease, LLC\"},\"image\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/curingheartdisease\",\"https:\\\/\\\/x.com\\\/RMHDInc\",\"https:\\\/\\\/www.instagram.com\\\/rmhdinc\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCm8dh9c_D5RfJL7Z1f-yY4w\"],\"description\":\"Curing Heart Disease, LLC is an independent cardiovascular health education organization that publishes evidence-based articles, videos, podcasts, and educational tools about cardiovascular disease prevention, lipid science, nutrition, exercise, and related health topics.\",\"founder\":{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\",\"name\":\"Peter Megdal, PhD\"},\"foundingPerson\":{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\",\"name\":\"Peter Megdal, PhD\"},\"knowsAbout\":[\"Cardiovascular health\",\"Cardiovascular disease prevention\",\"Heart disease education\",\"Nutrition\",\"Exercise\",\"Lipid science\",\"Atherosclerosis\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\",\"name\":\"Peter Megdal, PhD\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/peters-story\\\/\",\"givenName\":\"Peter\",\"familyName\":\"Megdal\",\"honorificSuffix\":\"PhD\",\"jobTitle\":\"Nutrition Researcher and Cardiovascular Health Educator\",\"description\":\"Peter Megdal, PhD, is a nutrition researcher, cardiovascular health educator, published researcher, and longtime competitive cyclist. He earned a PhD in nutrition from the University of Massachusetts and publishes evidence-based cardiovascular health education through Curing Heart Disease.\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/peters-story\\\/\"},\"worksFor\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"affiliation\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"alumniOf\":{\"@type\":\"CollegeOrUniversity\",\"name\":\"University of Massachusetts\"},\"knowsAbout\":[\"Nutrition\",\"Cardiovascular health education\",\"Cardiovascular disease prevention\",\"Lipid science\",\"Exercise physiology\",\"Scientific research\"],\"sameAs\":[\"https:\\\/\\\/www.curingheartdisease.com\\\/author\\\/peter-megdal\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/peter-megdal-56075a2\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u5fc3\u81d3\u75c5\u7ba1\u7406\u306e\u672a\u6765 - \u30d7\u30ec\u30df\u30a2\u5fc3\u81d3\u5065\u5eb7\u6559\u80b2\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.curingheartdisease.com\/ja\/\u5fc3\u75be\u60a3\u6cbb\u7642\u306e\u672a\u6765\/","og_locale":"ja_JP","og_type":"article","og_title":"The Future of Heart Disease Management - The Premiere Heart Health Education Platform","og_description":"Imagine you are looking at a beautiful house. The lawn is a perfect green. The windows are clean and shiny. From the street, the house looks brand new. But behind the walls, there is a \"ghost in the machine.\" The water pipes are old and rusty. The electric wires are fraying and sparking. You cannot see these problems just by looking at the outside. One day, a pipe bursts or a fire starts. Everyone is shocked. They say, \"But the house looked so good!\"","og_url":"https:\/\/www.curingheartdisease.com\/ja\/\u5fc3\u75be\u60a3\u6cbb\u7642\u306e\u672a\u6765\/","og_site_name":"The Premiere Heart Health Education Platform","article_publisher":"https:\/\/www.facebook.com\/curingheartdisease","article_published_time":"2026-01-13T14:16:18+00:00","article_modified_time":"2026-07-16T14:59:06+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/01\/post-image-21.jpg","type":"image\/jpeg"}],"author":"Peter Megdal PhD","twitter_card":"summary_large_image","twitter_creator":"@RMHDInc","twitter_site":"@RMHDInc","twitter_misc":{"\u57f7\u7b46\u8005":"Peter Megdal PhD","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"9\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/#article","isPartOf":{"@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/"},"author":{"name":"Peter Megdal PhD","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53"},"headline":"The Future of Heart Disease Management","datePublished":"2026-01-13T14:16:18+00:00","dateModified":"2026-07-16T14:59:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/"},"wordCount":1629,"publisher":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"image":{"@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/#primaryimage"},"thumbnailUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/01\/post-image-21.jpg","articleSection":["Lipids, Medications and Testing","Medications and Treatments","Risk Screening","Risk, Genetics and Special Populations"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/","url":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/","name":"\u5fc3\u81d3\u75c5\u7ba1\u7406\u306e\u672a\u6765 - \u30d7\u30ec\u30df\u30a2\u5fc3\u81d3\u5065\u5eb7\u6559\u80b2\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0","isPartOf":{"@id":"https:\/\/www.curingheartdisease.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/#primaryimage"},"image":{"@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/#primaryimage"},"thumbnailUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/01\/post-image-21.jpg","datePublished":"2026-01-13T14:16:18+00:00","dateModified":"2026-07-16T14:59:06+00:00","breadcrumb":{"@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/#primaryimage","url":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/01\/post-image-21.jpg","contentUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/01\/post-image-21.jpg","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.curingheartdisease.com\/the-future-of-heart-disease-management\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.curingheartdisease.com\/"},{"@type":"ListItem","position":2,"name":"The Future of Heart Disease Management"}]},{"@type":"WebSite","@id":"https:\/\/www.curingheartdisease.com\/#website","url":"https:\/\/www.curingheartdisease.com\/","name":"\u6700\u9ad8\u5cf0\u306e\u5fc3\u81d3\u5065\u5eb7\u6559\u80b2\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0","description":"\u5fc3\u75be\u60a3\u3092\u9006\u8ee2\u3055\u305b\u308b\u65b9\u6cd5\u306b\u95a2\u3059\u308b\u6700\u65b0\u306e\u60c5\u5831\u3092\u4e00\u822c\u306b\u5e83\u304f\u63d0\u4f9b\u3059\u308b\u3053\u3068\u3002\u3053\u308c\u306f\u3001\u98df\u4e8b\u3001\u904b\u52d5\u3001\u85ac\u7269\u7642\u6cd5\u3001\u305d\u306e\u4ed6\u306e\u30ea\u30bd\u30fc\u30b9\u3092\u542b\u3081\u3001\u3053\u306e\u75be\u60a3\u3068\u6700\u5584\u306e\u5f62\u3067\u95d8\u3046\u305f\u3081\u306b\u5229\u7528\u53ef\u80fd\u306a\u6700\u9ad8\u306e\u79d1\u5b66\u3092\u6d3b\u7528\u3059\u308b\u3001\u79d1\u5b66\u7684\u6839\u62e0\u306b\u57fa\u3065\u3044\u305f\u7d44\u7e54\u3067\u3042\u308b\u3002.","publisher":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.curingheartdisease.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/www.curingheartdisease.com\/#organization","name":"\u5fc3\u81d3\u75c5\u6cbb\u7642\u5408\u540c\u4f1a\u793e","url":"https:\/\/www.curingheartdisease.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/06\/cropped-Curing-Heart-icon-red.png","contentUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/06\/cropped-Curing-Heart-icon-red.png","width":512,"height":512,"caption":"Curing Heart Disease, LLC"},"image":{"@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/curingheartdisease","https:\/\/x.com\/RMHDInc","https:\/\/www.instagram.com\/rmhdinc\/","https:\/\/www.youtube.com\/channel\/UCm8dh9c_D5RfJL7Z1f-yY4w"],"description":"Curing Heart Disease, LLC\u306f\u3001\u5fc3\u8840\u7ba1\u75be\u60a3\u306e\u4e88\u9632\u3001\u8102\u8cea\u79d1\u5b66\u3001\u6804\u990a\u3001\u904b\u52d5\u3001\u304a\u3088\u3073\u95a2\u9023\u3059\u308b\u5065\u5eb7\u30c8\u30d4\u30c3\u30af\u306b\u95a2\u3059\u308b\u3001\u30a8\u30d3\u30c7\u30f3\u30b9\u306b\u57fa\u3065\u3044\u305f\u8a18\u4e8b\u3001\u52d5\u753b\u3001\u30dd\u30c3\u30c9\u30ad\u30e3\u30b9\u30c8\u3001\u6559\u80b2\u30c4\u30fc\u30eb\u3092\u516c\u958b\u3057\u3066\u3044\u308b\u3001\u72ec\u7acb\u3057\u305f\u5fc3\u8840\u7ba1\u5065\u5eb7\u6559\u80b2\u7d44\u7e54\u3067\u3059\u3002.","founder":{"@type":"Person","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53","name":"Peter Megdal, PhD"},"foundingPerson":{"@type":"Person","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53","name":"Peter Megdal, PhD"},"knowsAbout":["Cardiovascular health","Cardiovascular disease prevention","Heart disease education","Nutrition","Exercise","Lipid science","Atherosclerosis"]},{"@type":"Person","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53","name":"Peter Megdal, PhD","url":"https:\/\/www.curingheartdisease.com\/peters-story\/","givenName":"Peter","familyName":"Megdal","honorificSuffix":"PhD","jobTitle":"Nutrition Researcher and Cardiovascular Health Educator","description":"Peter Megdal, PhD\u6c0f\u306f\u3001\u6804\u990a\u7814\u7a76\u8005\u3001\u5fc3\u8840\u7ba1\u5065\u5eb7\u6559\u80b2\u8005\u3001\u8ad6\u6587\u3092\u767a\u8868\u3057\u3066\u3044\u308b\u7814\u7a76\u8005\u3067\u3042\u308a\u3001\u9577\u5e74\u306b\u308f\u305f\u308a\u7af6\u6280\u30b5\u30a4\u30af\u30ea\u30b9\u30c8\u3068\u3057\u3066\u3082\u6d3b\u52d5\u3057\u3066\u3044\u307e\u3059\u3002\u30de\u30b5\u30c1\u30e5\u30fc\u30bb\u30c3\u30c4\u5927\u5b66\u3067\u6804\u990a\u5b66\u306e\u535a\u58eb\u53f7\u3092\u53d6\u5f97\u3057\u3001\u300cCuring Heart Disease\u300d\u3092\u901a\u3058\u3066\u3001\u30a8\u30d3\u30c7\u30f3\u30b9\u306b\u57fa\u3065\u3044\u305f\u5fc3\u8840\u7ba1\u5065\u5eb7\u6559\u80b2\u306b\u95a2\u3059\u308b\u60c5\u5831\u3092\u767a\u4fe1\u3057\u3066\u3044\u307e\u3059\u3002.","mainEntityOfPage":{"@id":"https:\/\/www.curingheartdisease.com\/peters-story\/"},"worksFor":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"affiliation":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"alumniOf":{"@type":"CollegeOrUniversity","name":"University of Massachusetts"},"knowsAbout":["Nutrition","Cardiovascular health education","Cardiovascular disease prevention","Lipid science","Exercise physiology","Scientific research"],"sameAs":["https:\/\/www.curingheartdisease.com\/author\/peter-megdal\/","https:\/\/www.linkedin.com\/in\/peter-megdal-56075a2\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.curingheartdisease.com\/ja\/wp-json\/wp\/v2\/posts\/8587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curingheartdisease.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.curingheartdisease.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/ja\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/ja\/wp-json\/wp\/v2\/comments?post=8587"}],"version-history":[{"count":13,"href":"https:\/\/www.curingheartdisease.com\/ja\/wp-json\/wp\/v2\/posts\/8587\/revisions"}],"predecessor-version":[{"id":12115,"href":"https:\/\/www.curingheartdisease.com\/ja\/wp-json\/wp\/v2\/posts\/8587\/revisions\/12115"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/ja\/wp-json\/wp\/v2\/media\/8592"}],"wp:attachment":[{"href":"https:\/\/www.curingheartdisease.com\/ja\/wp-json\/wp\/v2\/media?parent=8587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/ja\/wp-json\/wp\/v2\/categories?post=8587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/ja\/wp-json\/wp\/v2\/tags?post=8587"}],"curies":[{"name":"\u304a\u75b2\u308c\u69d8\u3067\u3057\u305f","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}